INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 1 filers reported holding INTERSECT ENT INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,624,000 | +35.7% | 307,884 | +32.3% | 0.06% | +42.5% |
| Q4 2021 | $6,355,000 | +29.6% | 232,682 | +29.1% | 0.04% | +25.0% |
| Q3 2021 | $4,903,000 | +1764.3% | 180,254 | +1069.6% | 0.03% | +1500.0% |
| Q2 2021 | $263,000 | -18.8% | 15,411 | -0.6% | 0.00% | 0.0% |
| Q1 2021 | $324,000 | -46.6% | 15,500 | -41.5% | 0.00% | -50.0% |
| Q4 2020 | $607,000 | -8.6% | 26,500 | -34.9% | 0.00% | -20.0% |
| Q3 2020 | $664,000 | – | 40,698 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |